Gender-Affirming Care as a Predictor of HIV Pre-Exposure Prophylaxis Use and Adherence Among Young Trans Feminine Adults: A Coincidence Analysis
- PMID: 40478466
- PMCID: PMC12245996
- DOI: 10.1007/s11121-025-01814-x
Gender-Affirming Care as a Predictor of HIV Pre-Exposure Prophylaxis Use and Adherence Among Young Trans Feminine Adults: A Coincidence Analysis
Abstract
We used coincidence analysis to explore whether various forms of gender-affirming care (GAC) in the presence or absence of medical mistrust facilitate HIV pre-exposure prophylaxis (PrEP) use and adherence. Using secondary data collected between 2014 and 2024 from the RADAR Cohort Study, we performed two crisp-set coincidence analyses with 86 trans feminine young adults for PrEP use and 24 trans feminine young adults for PrEP adherence. Our final model for PrEP use explained over 90% of participants who had used PrEP in the past 6 months with 60% consistency. This model identified receipt of hormone replacement therapy (HRT) OR being on parental insurance as predictors of PrEP use. We identified two final models for PrEP adherence, which explained 50% of participants with 83% consistency: (1) past receipt of puberty blockers OR high suspicion of medical providers in the absence of parental insurance; (2) current or past receipt of HRT in the absence of barriers to GAC and the absence of parental insurance. Our study highlights the significant role of GAC in facilitating PrEP use and adherence among trans feminine individuals. Specifically, HRT and the absence of parental insurance emerged as key predictors, underscoring the need for integrated and accessible GAC to enhance PrEP uptake and adherence in this population.
Keywords: Gender-affirming surgery; HIV; Hormone replacement therapy; Pre-exposure prophylaxis; Puberty blockers; Transfeminine persons.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval and Informed Consent: This analysis was approved by the Northwestern University IRB as non-human subjects research and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. All RADAR study participants provided their consent for their data to be used in additional research, including secondary data analyses. Conflict of interest: The authors declare that they have no conflict of interest. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Third Coast Center for AIDS Research.
Similar articles
-
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26479. doi: 10.1002/jia2.26479. J Int AIDS Soc. 2025. PMID: 40600470 Free PMC article.
-
Inequities in HIV prevention among trans and/or non-binary people: a cross-sectional survey analysis of PrEP and PEP awareness and use in Spain.Int J Equity Health. 2025 Jul 7;24(1):197. doi: 10.1186/s12939-025-02574-4. Int J Equity Health. 2025. PMID: 40624632 Free PMC article.
-
Intention to Use Different Formulations of Longer Acting HIV Pre-Exposure Prophylaxis Among Transgender and Gender Expansive Individuals: The Roles of Social Vulnerability and Medical Mistrust.AIDS Patient Care STDS. 2024 Feb;38(2):51-60. doi: 10.1089/apc.2023.0211. AIDS Patient Care STDS. 2024. PMID: 38381948
-
Mobile Health Intervention Tools Promoting HIV Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa: Scoping Review.JMIR Mhealth Uhealth. 2025 Jun 20;13:e60819. doi: 10.2196/60819. JMIR Mhealth Uhealth. 2025. PMID: 40540732 Free PMC article.
-
Impact of mHealth on enhancing pre-exposure prophylaxis adherence and strengthening the HIV prevention cascade among key populations: a systematic review and meta-analysis.Front Public Health. 2025 Jun 26;13:1600773. doi: 10.3389/fpubh.2025.1600773. eCollection 2025. Front Public Health. 2025. PMID: 40642253 Free PMC article.
References
-
- Ambuehl, M., Baumgartner M. (2018). Baumgartner M. cna: Causal modeling with coincidence analysis. R Package Version, 2(1).
-
- Aryal, A., A Leibowitz, A., Comulada, W. S., Rotheram-Borus, M. J., Bolan, R., Ocasio, M. A., Swendeman, D., & Team, the A. C. S. (2023). PrEP use and HIV incidence among youth at-risk for HIV infection in Los Angeles and New Orleans: Findings from ATN 149. JAIDS Journal of Acquired Immune Deficiency Syndromes,94(3), 220. 10.1097/QAI.0000000000003272 - PMC - PubMed
-
- Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet. Infectious Diseases,13(3), 214–222. 10.1016/S1473-3099(12)70315-8 - PubMed
-
- Baumgartner, M., & Falk, C. (2023). Boolean difference-making: A modern regularity theory of causation. The British Journal for the Philosophy of Science,74(1), 171–197. 10.1093/bjps/axz047
-
- Becasen, J. S., Denard, C. L., Mullins, M. M., Higa, D. H., & Sipe, T. A. (2019). Estimating the prevalence of HIV and sexual behaviors among the US transgender population: A systematic review and meta-analysis, 2006–2017. American Journal of Public Health,109(1), e1–e8. 10.2105/AJPH.2018.304727 - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous